Xcout Intel
Spago Nanomedical competitors & alternatives
The 12 closest competitors and alternatives to Spago Nanomedical among health care companies — ranked by similarity to what Spago Nanomedical actually does, not by market-cap band.
Subscribe to see Spago Nanomedical’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
About Spago Nanomedical
Spago Nanomedical is a clinical-stage pharmaceutical company that develops precision nanomedicine products for the diagnosis and treatment of cancer and other severe diseases. Its pipeline includes Tumorad, a targeted radionuclide therapy for various cancers, and SpagoPix, a polymeric contrast agent designed to improve the precision of MRI diagnostics.
Spago Nanomedical at a glance
Spago Nanomedical is a health care company headquartered in Sweden. Xcout tracks 10 named people at Spago Nanomedical, including Mats Hansen (Chief Executive Officer (CEO)).
Spago Nanomedical leadership
- Mats HansenChief Executive Officer (CEO)
- Hanna OlssonChief Financial Officer (CFO)
- Paul HargreavesChief Development Officer (CDO)
- Alan RaffenspergerChairman of the Board
- Kari GrønåsBoard Member
- Mikael LönnBoard member
4 more named people on record for Spago Nanomedical, with roles, board committees and tenure — see the full roster →
Top 12 Spago Nanomedical competitors
Ranked by semantic similarity — how close each company is to Spago Nanomedical by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.
Healthcare
BAMF Health provides molecular imaging and radiopharmaceutical therapy services for patients suffering from conditions such as cancer and Alzheimer’s disease. The company utilizes advanced scanning technologies, including total-body PET/CT and whole-body MRI, to deliver intelligence-based precision medicine and personalized treatment plans.
Biotechnology
ImaginAb, Inc. is a global biotechnology company headquartered in California, with operations in Los Angeles and San Diego. It focuses on developing next-generation imaging and radiopharmaceutical products for cancer immunology.
Diagnostics
ABSCINT is a clinical-stage biotechnology company that develops platform production processes for rapid creation of cold kits for molecular imaging in oncology and immunology. Headquartered in Belgium, the privately held firm focuses on innovative diagnostic and therapeutic applications using single-domain antibodies.
Biotechnology
On Target Laboratories, Inc. is a biotechnology company founded in 2010 and headquartered in West Lafayette, Indiana. It discovers and develops targeted intraoperative molecular imaging agents to illuminate cancer during surgery.
Healthcare
PD Theranostics, Inc. (operating as United Theranostics) provides molecular imaging and precision radiopharmaceutical therapy for cancer patients, specializing in treatments for prostate cancer, neuroendocrine tumors, and thyroid cancer. The company utilizes advanced diagnostics such as PET and SPECT scans combined with targeted radiopharmaceuticals to deliver personalized, outpatient treatment plans. Additionally, they participate in clinical trials and collaborate with referring providers to offer innovative cancer care options.
Healthcare
Ractigen Therapeutics is a clinical-stage biopharmaceutical company headquartered in China that specializes in pioneering siRNA therapies designed to silence target genes.
Similar health care company
Sprint Bioscience is a pharmaceutical company that develops innovative preclinical drug candidates for cancer treatments. Utilizing a fragment-based drug discovery method, the company creates and out-licenses its drug programs to global pharmaceutical partners.
Similar health care company
FluoGuide is a biotechnology company that develops products for precision cancer surgery to improve patient outcomes. Its lead product, FG001, illuminates cancerous tissue during procedures to help surgeons perform more precise operations and reduce cancer recurrence.
Similar health care company
Faron Pharmaceuticals Oy is a clinical-stage biopharmaceutical company that develops novel immunotherapies and macrophage-targeting treatments for cancer patients. Its lead candidate, bexmarilimab, is an anti-Clever-1 antibody being evaluated in clinical trials for hematological cancers and solid tumors to improve the efficacy of standard cancer treatments.
Similar health care company
OncoZenge is a pharmaceutical development company that creates targeted treatments for oral pain, primarily focusing on oral mucositis caused by cancer radiotherapy and chemotherapy. Its lead product candidate, BupiZenge, is a bupivacaine-based lozenge designed to provide safe, local, and non-opioid pain relief for patients.
Healthcare
StandardX is a deep-tech company headquartered in London, United Kingdom, focused on developing rare isotopes for cancer treatment and fusion energy. The company is building sovereign isotope supply chains for Britain and Europe to enhance regional industrial resilience.
Similar health care company
Nanexa is a pharmaceutical company that develops long-acting injectable drug products using its proprietary PharmaShell drug delivery system, which utilizes atomic layer deposition technology. The company creates its own pipeline of treatments and collaborates with pharmaceutical partners, such as Moderna, to enable extended-release therapies for indications including diabetes, cancer, cardiovascular diseases, and psychiatric disorders.
Analyze another company
Search any company we track to see its competitive set.
Or describe a company
Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.
See the full profile of Spago Nanomedical and its market
Funding, investors, tech stack, hiring signals, leadership and corporate events — for Spago Nanomedicaland every competitor above — in one live dashboard.
Subscribe to Xcout Intel →